Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo

M

Minia University

Status and phase

Unknown
Phase 2

Conditions

Ovarian Stimulation

Treatments

Drug: HHMG

Study type

Interventional

Funder types

Other

Identifiers

NCT04539067
635_5/2020

Details and patient eligibility

About

Investigate and compare the efficacy of H FSH plus HMG Vs HMG alone on oocyte and embryo quality in IcsI patients

Full description

70 patients divided in to 2groups Group A controlled ovarian stimulation with H FSH and HHMg Group B controlled ovarian stimulation with HMG alone Results will be discussed later

Enrollment

70 estimated patients

Sex

Female

Ages

20 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

1. Infertil women aged from 20_35yr 2. Normal utreus 3. Normal ovaries 4. unexplained infertility 5. no endometriosis

Exclusion criteria

1 - poor responders to gonadotropin 2-Prior history of more than 3unsucceful ICSI 3-Any malformation of sexual organs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

HMG group
Experimental group
Description:
Induction of ovulation from 2nd day of cycle Follow diameter of follicle When follicle 18:22mm Receive HMG
Treatment:
Drug: HHMG
H FSH plus HHMG
Experimental group
Description:
Follow up ovulation from the 2nd day to 5th of menstruation cycle When follicle diameter 18mm to 22mm made induction of ovulation
Treatment:
Drug: HHMG

Trial contacts and locations

0

Loading...

Central trial contact

Marwa Ba Tarahony; Kareem Ib Shaheen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems